SUNITINIB KRKA 12,5 mg, gélule — 30 plaquette(s) pelable(s) OPA : polyamide orienté aluminium polyéthylène de 1 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930234273
  • CIP7 3023427
  • CIS 64232082

What the source publishes

Holder
KRKA (SLOVENIE)
Active ingredients
SUNITINIB, MALATE DE SUNITINIB
Form
gélule
Package
30 plaquette(s) pelable(s) OPA : polyamide orienté aluminium polyéthylène de 1 gélule(s)
Routes
orale
Administrative status
cancelled
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2021-06-16
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930234273
{
  "cis": "64232082",
  "cip7": "3023427",
  "form": "gélule",
  "name": "SUNITINIB KRKA 12,5 mg, gélule — 30 plaquette(s) pelable(s) OPA : polyamide orienté aluminium polyéthylène de 1 gélule(s)",
  "cip13": "3400930234273",
  "holder": "KRKA (SLOVENIE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "KRKA (SLOVENIE)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "512.88",
  "authorisedOn": "2021-06-16",
  "compositions": [
    {
      "name": "SUNITINIB",
      "nature": "FT",
      "strength": "12,5 mg",
      "linkageNumber": "1",
      "substanceCode": "29335",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "MALATE DE SUNITINIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "41239",
      "dosageReference": null,
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "511.86",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SUNITINIB KRKA 12,5 mg, gélule",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "30 plaquette(s) pelable(s) OPA : polyamide orienté aluminium polyéthylène de 1 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100 %"
  ],
  "marketingDeclaredOn": "2024-02-29",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SUNITINIB",
    "MALATE DE SUNITINIB"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930234273"